Advanced Biomed Inc (ADVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,982 | 6,471 | -387 | -3,259 | -2,557 |
| Depreciation Amortization | 45 | 35 | 48 | 344 | 68 |
| Other Working Capital | 571 | 331 | -272 | -2,910 | -4,202 |
| Other Operating Activity | -7,961 | -7,961 | 0 | 0 | 2,411 |
| Operating Cash Flow | $-1,364 | $-1,124 | $-610 | $-5,825 | $-4,281 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -15 | -2 | -32 | -12 |
| Investing Cash Flow | $-16 | $-15 | $-2 | $-32 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 142 | 139 | N/A | N/A | 764 |
| Debt Repayment | N/A | N/A | 449 | -600 | N/A |
| Common Stock Issued | 248 | N/A | 10 | 5,790 | 5,602 |
| Common Stock Repurchased | N/A | -18 | -11 | N/A | -1 |
| Other Financing Activity | 642 | 642 | 0 | 744 | 335 |
| Financing Cash Flow | $1,031 | $763 | $448 | $5,934 | $6,700 |
| Exchange Rate Effect | 53 | 82 | -83 | 218 | 169 |
| Beginning Cash Position | 2,904 | 2,904 | 2,904 | 2,608 | 2,608 |
| End Cash Position | 2,609 | 2,611 | 2,657 | 2,904 | 5,184 |
| Net Cash Flow | $-295 | $-293 | $-247 | $296 | $2,576 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,364 | -1,124 | -610 | -5,825 | -4,281 |
| Capital Expenditure | -16 | -15 | -2 | -32 | -12 |
| Free Cash Flow | -1,380 | -1,139 | -612 | -5,857 | -4,293 |